Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
Candinas
D
D
Liver Research Laboratories, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom.
Achilleos
O
O
Lee
S J
SJ
Dalgic
A
A
Mayer
A D
AD
Buckels
J A
JA
McMaster
P
P
D'Silva
M
M
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D016559:Tacrolimus / Q000627:therapeutic use; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D016572:Cyclosporine; D000077339:Leflunomide; D016559:Tacrolimus